Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Pancreatic Neoplasms 4Colorectal Neoplasms 4Breast Neoplasms 4Prostatic Neoplasms 3Ovarian Neoplasms 3Triple Negative Breast Neoplasms 2Stomach Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma, Ewing 2Carcinoma, Non-Small-Cell Lung 2Wilms Tumor 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Osteosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Neoplasms 1Neoplasm Metastasis 1Mesothelioma 1Hepatoblastoma 1Gastrointestinal Neoplasms 1Fanconi Anemia, Complementation Group D1 1Carcinoma, Renal Cell 1Carcinoma, Ovarian Epithelial 1

Interventions

X-Rays 6Magnetic Resonance Spectroscopy 6Specimen Handling 5Phantoms, Imaging 5Nuclear Medicine Department, Hospital 4Melphalan 4fludarabine 3Granulocyte Colony-Stimulating Factor 3Cyclophosphamide 3Busulfan 3Biopsy 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2larotrectinib 2ivosidenib 2ensartinib 2Vemurafenib 2Trabectedin 2Thiotepa 2Temozolomide 2Sirolimus 2Mesna 2LY3023414 2Cytoreduction Surgical Procedures 2Cisplatin 2talazoparib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rhabdomyosarcoma × talazoparib × Gastrointestinal × Clear all
NCT04901702 2026-05-19

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

St. Jude Children's Research Hospital

Phase 1/2 Recruiting
90 enrolled
CNSGastrointestinalGenitourinarySarcoma

Neoplasms, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Peripheral, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡